Articles tagged with Protein Kinases
The kinase field offers significant therapeutic opportunities, with many understudied kinases waiting to be explored. Recent advances in chemical probe development and resource availability have led to a shift towards more systematic exploration of previously neglected targets.
Researchers at St. Jude Children's Research Hospital identified a protein network that stabilizes ABCC4 transporters in place to maintain cyclic AMP signaling levels. The discovery reveals a previously unappreciated protein neighborhood and opens new therapeutic opportunities for regulating ABC transporters.
Researchers at Okayama University developed a novel AAK1 inhibitor using Kinobeads technology, shedding light on its inhibitory mechanism and targeting various neurological disorders and viral infections. This breakthrough paves the way for rapid and cost-effective enzyme inhibitors with clinical applications.
Researchers successfully generated viable and heritable knockout mutants for three essential protein kinases using CRISPR/Cas9 genome editing. These mutants displayed severe developmental defects and enhanced disease resistance, providing valuable resources for gene function studies and signaling network regulation.
A new molecular compound has been identified that can activate latent HIV-1 in cells, showing promise for HIV treatments. Researchers found that this compound, YSE028, can reactivate latently infected cells and induce cell death, potentially leading to a complete cure for HIV.